HIGHLIGHTS
- who: Remco T. P. van Cruchten from the Center for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands have published the research: Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood, in the Journal: (JOURNAL)
- what: To maximize the generalizability of the study findings, the goal of the patient sampling was to obtain a balanced subset of the OPTIMISTIC Patients of the OPTIMISTIC intervention arm were treated with a personalized form of CBT. This analysis has been implemented using lme . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.